Skip to main content
. 2013 May 29;6(2):317–322. doi: 10.3892/ol.2013.1367

Figure 3.

Figure 3.

A hypothesis is associated with antitelomerase strategy. The antitelomerase strategy, created by combining epigenetic modifiers with telomerase hTR subunit small molecule inhibitors (such as SOT-095), may exert a more potent effect for the treatment of human leukemia, since each approach is able to individually inhibit telomerase activity. hTERT, human telomerase reverse transcriptase.